Best Life Sciences Companies in Spain
The 620 best Life Sciences companies in Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Sanifit.
Spain's Life Sciences sector is moving fast, and this directory ranks 620 companies operating there by disclosed equity funding and recent funding momentum. Total disclosed capital sits at $1.9B across the cohort, with UDx leading at $126M raised, followed by Oncomatryx at $26M and Biorce at $62M. No unicorns yet, but the pipeline is real. Europa, EIC Fund, and Caixa Capital Risc are the names showing up repeatedly on cap tables, which tells you something about where institutional conviction is concentrated right now.
The global backdrop isn't slowing anyone down. According to Morgan Stanley's recent read on life science tools, analyst upgrades are tracking a sector that's still expanding, consistent with a global market CAGR of roughly 10.2%. Aging demographics and sustained public funding are the demand engine. I'd also flag that Sai Life Sciences' IPO move signals broader investor appetite for exits in this space, a sentiment Spain's maturing cohort will eventually test. Peptomyc, Pharmacelera, Biohope: all sub-$30M raises so far, but watch the next 18 months.
- What Drives San Diego's Life Sciences Industry
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Spain
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sanifit Developer of drugs for the treatment of cardiovascular, renal, osteoporosis, and oral-dental diseases | $130M | 83 mo ago | Acquired | 31 | — | — | — | — |
| 2 | UDX Developer of non-invasive blood-based diagnostics for cancer | $126M | 4 mo ago | Series C | 61 | Marko Bitenc Co-Founder | WebflowApple iCloud MailMicrosoft 365+11 | — | — |
| 3 | Minoryx Developer of therapies for rare neurometabolic diseases | $107M | 43 mo ago | Series D | 33 | Joan Aymami Co-Founder | PHPApache HTTP ServerCloudflare+11 | — | — |
| 4 | INBRAIN Neuroelectronics Developer of implantable neurotechnology for decoding and modulating brain activity | $83M | 13 mo ago | Series B | 52 | Kostas Kostarelos Co-Founder | WordPressPleskMySQL+17 | 43 patents Implantable flexible brain electrodes and neurostimulation delivery systems | 1 partnership |
| 5 | MedLumics Developer of biological tissue imaging by using optical coherence tomography | $63M | 49 mo ago | Series E | 29 | — | — | 253 patents Intravascular optical imaging and laser ablation guidance using fiber‑based catheters | — |
| 6 | Biorce Provider of a clinical assistant platform for drug development | $62M | 4 mo ago | Series A | — | Diogo Pisoeiro Co-Founder & Chief Product Officer | Framer SitesApple iCloud MailGoogle Workspace+19 | — | 1 launch |
| 7 | Splice Bio Provider of a proprietary platform for gene therapy 37Funding top 29%Growth top 45%Moat top 48%Tech bottom 49% All 7 signals ▾Fundingtop 29% Growthtop 45% Moattop 48% Techbottom 49% Talentbottom 49% Globalbottom 38% Marketbottom 33% Funding: Raised $56.7M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 37/100 | $57M | 12 mo ago | Series B | 24 | Miquel Vila-Perello CEO | WordPressMySQLPHP+22 | — | — |
| 8 | Ona Therapeutics Provider of therapeutics solution for metastatic cancer | $35M | 8 mo ago | Series A | 25 | Valerie Vanhooren Co-Founder & CEO | WordPressBugHerdMySQL+19 | 30 patents FGFR4 and CD36 targeted therapeutics for cancer treatment | — |
| 9 | DeepUll Developer of diagnostic technology for rapid identification of sepsis-causing pathogens | $35M | 13 mo ago | Series C | 26 | Rafel Gibert Co-Founder | PHPNginxCloudflare+11 | — | — |
| 10 | SOM Biotech Developer of platform for screening compounds to treat rare diseases | $29M | 30 mo ago | Series B | 15 | Raul Insa Founder & CEO | — | 117 patents Pharmaceutical compounds and formulations for treating dystrophinopathies, movement disorders, and PKU | — |
| 11 | Highlight Therapeutics Developer of RNA-based therapies for dermato-oncology conditions and skin cancers | $27M | 9 mo ago | Series B | 23 | — | WordPressMySQLPHP+15 | 37 patents Formulating dsRNA poly‑I:C with polyalkyleneimine for immunotherapy drug delivery | — |
| 12 | Oncomatryx Developer of antibody-drug conjugates targeting the tumor microenvironment | $26M | 2 mo ago | Series D | 19 | — | WordPressMySQLPHP+14 | — | — |
| 13 | ORYZON Developer of treatments solutions for cancer and neurodegenerative diseases using epigenetic technology… | $25M | 13 mo ago | Public | 43 | Carlos Buesa CEO | DrupalApple iCloud MailMicrosoft 365+10 | — | — |
| 14 | Peptomyc Cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment | $23M | 2 mo ago | Series C | 18 | Marie-Eve Beaulieu Co-Founder | WordPressMySQLPHP+16 | 60 patents Patents concentrated in health & consumer products | — |
| 15 | Aortyx Developer of smart devices for aortic diseases | $21M | 12 mo ago | Series A | 19 | Vincente Riambau Co-Founder | — | 3 patents Navigable intravascular catheters for precise minimally invasive procedures | — |
| 16 | AbilityPharma Developer of drugs for the treatment of cancer diseases | $15M | 27 mo ago | Series B | 19 | Jordi Espadaler Co-Founder | Google MapsApache HTTP Serverlit-html+7 | — | — |
| 17 | Vaxdyn Prophylactic vaccines against multidrug resistant bacterial infections | $14M | 21 mo ago | Series A | 8 | — | — | 20 patents LPS-deficient multivalent vaccines targeting Acinetobacter baumannii infections | — |
| 18 | Geniova Technologies Developer of clear aligner orthodontic system integrating archwire and 3D-printed components | $13M | 16 mo ago | Series B | — | — | Cart FunctionalityWooCommerceWordPress+31 | 9 patents Patents concentrated in health & consumer products | — |
| 19 | Iomed Health Provider of an AI-based Software for collecting EMR for clinical research | $13M | 33 mo ago | Series A | — | Gabriel Maeztu Co-Founder | — | — | — |
| 20 | ADmit Therapeutics Provider of diagnostic services for early detection of Alzheimer's disease | $13M | 32 mo ago | Series A | 10 | Jordi Gascon Co-Founder | — | 18 patents Diagnostic biomarkers for Lewy body dementia and Alzheimer’s disease risk assessment | — |
| 21 | Laminar Pharma Developer of melipathy based drugs | $12M | 22 mo ago | Series A | 30 | — | WordPressPleskMySQL+29 | — | — |
| 22 | Sequentia biotech Bioinformatics technologies and sevices | $11M | 20 mo ago | Series A | 23 | — | WordPressPleskMySQL+24 | — | — |
| 23 | Quibim Developer of medical imaging software for radiomics and biomarker analysis | $10M | 16 mo ago | Series A | 90 | Luis Marti-Bonmati Co-Founder | WordPressApple iCloud MailMicrosoft 365+36 | 32 patents AI-based medical imaging analysis: segmentation, anomaly detection, harmonization, and biomarker extraction. | 3 launchs |
| 24 | Pharmacelera Hardware and software solutions for computer-aided drug design | $10M | 3 mo ago | Series A | 24 | Enric Codina Co-Founder & CEO | WordPressZohoMySQL+22 | 4 patents AI-driven molecular design and similarity analysis for drug discovery | 1 partnership |
| 25 | Biohope Assay solutions for management of kidney transplant patients | $9M | 1 mo ago | Seed | 31 | Isabel Portero Founder & CEO | WordPressMySQLPHP+18 | — | — |
| 26 | ARTHEx Developer of oligonucleotide therapies for neuromuscular diseases | $8M | 9 mo ago | Series B | 15 | — | WebflowReactstyled-components+11 | — | — |
| 27 | Onechain Immunotherapeutics Developer of immunotherapies against hematological malignancies | $7M | 27 mo ago | Seed | 10 | Pablo Menendez Founder | RubyTrixYouTube+7 | 28 patents Targeted antibody-based immunotherapies and engineered Vδ1 T-cell therapies for cancer | 1 internship |
| 28 | Oxolife Developer of a first-in-class oral drug improving embryo implantation | $7M | 3 mo ago | Series A | 10 | Ignasi Almazan Co-Founder | WordPress Block EditorWordPressMySQL+18 | 80 patents Tungsten(VI) salt hydrates for fertility therapeutics and their manufacturing processes | — |
| 29 | Amadix Provider of diagnostic tools to support personalized cancer treatment | $7M | 16 mo ago | Series A | 35 | Rocio Arroyo CEO | WordPress Block EditorElementorWordPress+25 | — | — |
| 30 | Integra Therapeutics Developer of next generation of gene editing tools to cure diseases | $7M | 9 mo ago | Seed | 9 | Marc Guell Co-Founder | WordPressMySQLPHP+18 | 10 patents Transposase-mediated gene delivery systems for enhanced transgene expression and nuclear localization | — |
| 31 | Be Levels Developer of nutritional supplements to enhance overall health and well-being | $7M | 20 mo ago | Series A | 11 | — | Cart FunctionalityShopifySearchanise+32 | — | 1 job opening |
| 32 | Orikine Bio Developer of therapeutics for the treatment of immune-mediated diseases | $6M | 18 mo ago | Seed | — | Ariadna Blay Co-Founder | — | — | — |
| 33 | Iteria Biopharma Developer of medicinal chemistry treatments for difficult to modulate targets | $6M | 2 mo ago | Seed | — | Julio Castro Co-Founder | WordPressMySQLPHP+24 | — | — |
| 34 | Voxelcare Developer of CAD/CAM application for foot-care and footwear industry 37Growth top 35%Moat top 38%Funding top 43%Patents top 45% All 10 signals ▾Growthtop 35% Moattop 38% Fundingtop 43% Patentstop 45% Innovationbottom 49% Talentbottom 49% Productbottom 48% Techbottom 47% Globalbottom 40% Marketbottom 25% Growth: Fresh capital in last 24 mo Moat: Editorial + unicorn rating 4/10 · IP moat: 18 patents rank vs industry peers · Fliar Intelligence Index 37/100 | $6M | 16 mo ago | Series A | — | Michael Lampert Co-Founder & CEO | Cart FunctionalityNode.jsGoogle Maps+23 | 18 patents Granule-based additive manufacturing for orthopedic insole production and related medical devices | — |
| 35 | IVB Wellness Lab Provider of nutritional supplements to improve health and wellness | $6M | 21 mo ago | Seed | — | Valerio Soto Ferri Co-Founder & CEO | Cart FunctionalityShopifyZURB Foundation+36 | — | 5 job openings |
| 36 | MedicSen Mobile app to manage diabetes | $6M | 25 mo ago | Seed | 15 | — | — | — | — |
| 37 | Abanza Tecnomed Manufacturer of soft tissue fixation devices for orthopedic and sports medicine | $5M | 21 mo ago | Seed | 18 | Juan Abascal Azanza Co-Founder & CEO | TurbopackEmotionNode.js+13 | 47 patents Orthopedic surgical instruments for bone tunnel creation, rupturing tools, and related implants | 1 award |
| 38 | Gyala Therapeutics Developer of cell therapies for the treatment of hematological malignancies | $4M | 4 mo ago | Early Stage | 5 | — | — | 9 patents CD84-targeted antibodies and CAR‑T cell immunotherapies for cancer treatment | — |
| 39 | VIVEbiotech Developer and manufacturer of lentiviral vectors | $4M | 18 mo ago | Seed | 83 | Gurutz Linazasoro Founder & CEO | WordPressMySQLPHP+16 | — | — |
| 40 | Adaptam Therapeutics Developer of antibody-based immunotherapies targeting the immunosuppressive myeloid tumor microenvironment | $3M | 7 mo ago | Seed | — | Asis Palazon Founder & CEO/CSO | — | 4 patents Therapeutic antibodies targeting Siglec‑9 and Siglec‑15 immune‑checkpoint proteins | — |
| 41 | Aptadel Therapeutics Developer of RNA-based therapeutics to treat cancer | $3M | 2 mo ago | Seed | 7 | Oscar Tirado Co-Founder | — | 3 patents Aptamer therapeutics targeting EPHA2 receptor for cancer treatment | 1 job opening · 1 launch |
| 42 | Methinks Provider of AI and cloud-based software for the diagnosis of strokes | $3M | 2 mo ago | Seed | 17 | Cristian Marti Founder | WebflowApple iCloud MailMicrosoft 365+12 | — | 1 job opening |
| 43 | Irisbond Developer of eye tracking solution to control a computer for disabled individuals 32Growth top 35%Talent bottom 49%Market bottom 43%Funding bottom 42% All 7 signals ▾Growthtop 35% Talentbottom 49% Marketbottom 43% Fundingbottom 42% Globalbottom 29% Techbottom 26% Newsbottom 22% Growth: Fresh capital in last 24 mo Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 32/100 | $2M | 14 mo ago | Series A | 46 | Eduardo Torrecilla Founder & CEO | WordPressMySQLPHP+12 | — | 1 job opening · 1 partnership · 2 awards |
| 44 | Superlativa Provider of supplements for stress relief, hormonal balance, and digestive health | $2M | 18 mo ago | Seed | — | Teresa Pueyo Founder & CEO | Cart FunctionalityShopifySentry+45 | — | 1 award |
| 45 | ZYMVOL Provider of enzyme engineering services using computational and AI-driven molecular modeling | $1M | 15 mo ago | Seed | 28 | Maria Lucas Co-Founder & CEO | WordPressMySQLPHP+21 | — | 1 launch |
| 46 | ADNTRO Provider of saliva-based DNA testing kits for genetic studies | $1M | 20 mo ago | Seed | — | Guillermo Pérez-Solero Monzon CEO & Founder | WordPressMySQLRedis+39 | — | — |
| 47 | Genomcore Provider of a platform for personal genomic analysis | $985K | 18 mo ago | Series A | — | Miquel Angel Bru Co-Founder | WordPressApple iCloud MailGoogle Workspace+22 | 4 patents Secure data access control for wireless communication networks | — |
| 48 | Pragmatech Provider of artificial intelligence solutions with a focus on clinical microbiology and infectious diseases | $771K | 5 mo ago | Seed | — | Pablo Valledor Co-Founder | — | — | — |
| 49 | Genbioma Developer of probiotic supplements for predicabetics | $544K | 16 mo ago | Seed | 5 | Josune Ayo CEO | — | — | — |
| 50 | Robopedics Developer of robotic orthopedic solution for people with walking disabilities | $291K | 11 mo ago | Seed | — | Ivan Martinez Founder | Webflowlit-htmllit-element+12 | — | — |
Top 12 Life Sciences companies in Spain
#1
Series C · Seville, Andalusia · founded 2012 · 61 employees$126.1Mraised▾
Developer of non-invasive blood-based diagnostics for cancer. The company is developing a screening test that uses metabolomics to analyze patient blood samples and detect early signs of disease. It has developed tests for the early detection of colorectal cancer, lung cancer, and breast cancer.
- Jan 2026Series C$35M
- Feb 2025Venture Debt$21M
- Aug 2024Series B—
- Nov 2023Series B$70M
#2
Series A · Barcelona, Catalonia · founded 2024$61.5Mraised▾
Provider of a clinical assistant platform for drug development. It uses AI technology to de-risk and accelerate clinical trials, streamlining the process for pharmaceutical companies
- Feb 2026Series A$52M
- Jul 2025Seed$5.8M
- Nov 2024Seed$3.7M
#3
Series C · Barcelona, Catalonia · founded 2014 · 18 employees$22.6Mraised▾
Peptomyc, a spin-off of the Vall d’Hebron Institute of Oncology (VHIO) is focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. Its lead peptide Omomyc-CPP is in the preclinical stage.
- Apr 2026Series C$5.8M
- Feb 2026Series B—
- Oct 2023Grant (prize money)$2.6M
- Oct 2023Series B$2.6M
#4
Series D · Derio, Basque Country · founded 2009 · 19 employees$26.2Mraised▾
Developer of antibody-drug conjugates targeting the tumor microenvironment. It develops novel therapies focused on modulating the tumor's microenvironment to overcome resistance to conventional cancer treatments. The company conducts clinical trials and is committed to bringing innovative solutions to cancer patients. Research efforts concentrate on understanding and targeting the tumor stroma, a new avenue for treating metastatic solid tumors. This approach involves orchestrated combinations of precision drugs targeting both the tumor and its surrounding microenvironment.
- Mar 2026Series D$67M
- Jan 2025Series C$26.2M
- Apr 2022Series B$16.2M
- Nov 2019Series A$10M
#5
Seed · Tres Cantos, Community of Madrid · founded 2015 · 31 employees$8.5Mraised▾
Biohope develops assay solutions for the management of organ rejection in kidney transplant patients. Its flagship product is a 3D-cell culture that enables physicians to tailor immunosuppressants for renal transplant patients. This assay can be used to prescribe a treatment regimen that prevents organ rejection, and adverse immune reactions due to overuse of immunosuppressants.
- May 2026Seed—
- Jun 2019Grant (prize money)$4.4M
- Jan 2017Grant (prize money)$4M
- Jun 2016Grant (prize money)—
#6
Series A · Barcelona, Catalonia · founded 2015 · 24 employees$9.5Mraised▾
Hardware and software solutions for computer-aided drug design. Products include PharmScreen- a ligand-based virtual screening tool that uses a 3D ligand-alignment algorithm based on the interaction fields for lead generation, and PharmQSAR- a 3D Quantitative Structure-Activity Relationship (QSAR) tool able to combine multiple fields of interaction.
- Feb 2026Series A$7.1M
- Aug 2022Grant (prize money)$50.1K
- Sep 2020Grant (prize money)$1.1M
- Apr 2020Grant (prize money)$1.1M
#7
Series A · Barcelona, Catalonia · founded 2019 · 25 employees$35.5Mraised▾
Ona Therapeutics provides therapeutics solution for metastatic cancer. It is a spin-off of ICREA and IRB and involved in developing biologics targeting the metastatic-initiating cells and lipid metabolism for the treatment of cancer.
- Oct 2025Series A$11.6M
- Dec 2020Grant (prize money)—
- Jun 2020Series A$33.8M
- May 2019Seed$1.7M
#8
Series B · Barcelona, Catalonia · founded 2019 · 52 employees$82.8Mraised▾
Developer of implantable neurotechnology for decoding and modulating brain activity. The company focuses on creating bi-directional, high-resolution brain-computer interfaces. These interfaces enable real-time smart neural decoding and modulation in closed loop. The company's platform combines hardware and data analytics to personalize therapy.
- May 2025Grant (prize money)$4.5M
- Oct 2024Series B$50M
- Dec 2023Venture Debt$22.1M
- Oct 2023Series A—
#9
Seed · Spain · founded 2024$5.9Mraised▾
Developer of medicinal chemistry treatments for difficult to modulate targets. This entity focuses on the application of chemical methods to address medical needs in oncology. Research efforts target pharmacologically validated proteins that are resistant to standard drug discovery techniques. Development activities include the creation of candidates protected by intellectual property rights and the management of projects through early development stages.
- Apr 2026Seed$5.9M
#10
Series A · Barcelona, Catalonia · founded 2013 · 10 employees$7Mraised▾
Developer of a first-in-class oral drug improving embryo implantation. It offers a drug, OXO-001, to increase embryo implantation success and pregnancy rates. It addresses implantation failure or early pregnancy loss, major causes of failure in female fertility treatments. The company is also studying the use of OXO-001 to treat infertility associated with Polycystic ovary syndrome (PCOS).
- Feb 2026Grant (prize money)$3M
- Dec 2022Grant (prize money)$2.5M
- 2020Seed$1.4M
- Jun 2020Series A$5.7M
#11
Series B · Paterna, Valencian Community · founded 2010 · 23 employees$27.1Mraised▾
Developer of RNA-based therapies for dermato-oncology conditions and skin cancers. Its lead drug candidate triggers immune responses, transforming tumors, making them visible. The company focuses on research and therapies offering hope for healthier skin. It aims to address the challenges behind common cancers.
- Sep 2025Series B$17.6M
- Feb 2021Series B$27.1M
- Jan 2015Grant (prize money)$299.6K
#12
Series B · Barcelona, Catalonia · founded 2020 · 24 employees$56.7Mraised▾
Provider of a proprietary platform for gene therapy. The company offers proprietary intein platform technology for treating patients suffering from rare genetic diseases. The company's lead program is in Stargardt disease, the most common inherited retinal disorder caused by mutations in a single gene ABCA4.
- Jun 2025Series B$135M
- Feb 2022Series A$56.7M
- Sep 2020Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Spain
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,045 Spain-affiliated papers.
- Universidad Internacional De La Rioja128
- Consejo Superior de Investigaciones Científicas40
- Universidad Complutense de Madrid29
- Universidade de Santiago de Compostela27
- University of Córdoba26
- Population1→5
- Flow cytometry1→5
- Mutant1→4
- DNA damage3→4
- Gene1→15
- Agriculture1→15
- Health benefits2→9
- Germplasm1→8
- In vivo2→8
- Agriculture2→15
- Context (archaeology)1→13
- Antibiotic resistance2→11
- Antimicrobial1→9
- Production (economics)1→9
Where biotechnology is researched across Spain
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.